BPA call under BPA HHSF223201700015B entitled, consultative services and external peer review for scientific assessments completed by the division of risk and decision analysis
Ended Awarded Last action
- Contract number
- 75F40121F19015
- Awardee
-
Versar, Inc. UEI KTERFRZBVP66
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $54,588
Award facts
- Contract value 100% obligated
- $54,587.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541620 Environmental Consulting Services
- PSC
- R499 Support- Professional: Other
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Springfield, VA 22151, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$28,678 | |
| Other Administrative Action | $0 | |
| Original award | $83,266 |
About this award
This contract modification represents the de-obligation and closeout of a Blanket Purchase Agreement (BPA) call awarded to Versar, Inc. under BPA HHSF223201700015B by the Food and Drug Administration. The BPA call, valued at $54,587.99 on a firm fixed-price basis, was designed to provide consultative services and external peer review for scientific assessments completed by the FDA's Division of Risk and Decision Analysis. The work was performed in North Springfield, Virginia, with an ultimate completion date of October 31, 2022. This modification concludes the contract by de-obligating remaining funds and formally closing out the award.
Versar, Inc., a Washington, D.C.-headquartered professional services and project management firm, competed in open competition for this award without any small business set-aside designation. The contractor brings substantial experience in scientific peer review and risk assessment services across federal agencies, supported by significant indefinite delivery vehicles including a $4.6 million EPA Blanket Purchase Agreement and a $999.999 trillion OASIS+ contract with the General Services Administration. Versar's engagement with the FDA under this BPA reflects the company's specialized capability in providing external technical and scientific review services that support agency decision-making and regulatory assessments.
Quick answers
Who was awarded contract 75F40121F19015?
75F40121F19015 was awarded to Versar, Inc. by Food and Drug Administration (Department of Health and Human Services) on March 9, 2021.
How much is contract 75F40121F19015 worth?
The government has obligated $54,588 on 75F40121F19015.
Is contract 75F40121F19015 an order under another contract?
Yes. 75F40121F19015 is a BPA call under GS00F0007L-HHSF223201700015B, a blanket purchase agreement, on The Professional Services Schedule (PSS).
Was contract 75F40121F19015 competed?
The extent of competition for 75F40121F19015 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award